Stay updated on Nivolumab Plus Ipilimumab in Renal Medullary Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in Renal Medullary Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab in Renal Medullary Carcinoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The 403 Forbidden message and its Home link disappear, leaving the ClinicalTrials.gov page shell without visible study details. The site revision changes from v3.7.2 to v3.8.0.
    Difference
    0.6%
    Check dated 2026-11-01T01:11:27.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    A banner announces NIH website transition updates and says both “Super Intelligence” and “Artificial Intelligence” terminology may appear during the transition.
    Difference
    1%
    Check dated 2026-10-25T01:11:31.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.1 to v3.7.2 while the page continues to show a 403 error.
    Difference
    0.2%
    Check dated 2026-10-18T00:56:14.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The footer revision number changed from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-11T01:36:53.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with minimal navigation. The prior detailed study content and metadata have been removed, indicating an error state rather than an update to the study data.
    Difference
    20%
    Check dated 2026-09-20T00:22:51.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.6, indicating a CMS/content update. This change does not modify the study details or related information.
    Difference
    0.1%
    Check dated 2026-08-29T20:52:58.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab in Renal Medullary Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in Renal Medullary Carcinoma Clinical Trial page.